|
Product complaint number: (b)(4).If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested, and the following was obtained: what is the procedure & event date? =>no further information is available.What was used to complete the procedure? =>no further information is available.What is the lot number? =>no further information is available.Device return follow up.=>we regularly contact with sales rep about the device returning.No further information will be provided.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent this is a combination product, and the event has been reviewed for both the suture and the triclosan.Ingredient(s)- triclosan, dosage form - suture/solid/parenteral, strength -= 275 ¿g /m.
|
|
Product complaint # (b)(4).Date sent to the fda: 3/10/2022.This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Investigational summary: the product was returned to ethicon inc for evaluation.Visual analysis of the returned product revealed that one sample product code vcp790 was received for evaluation with the packaging previously opened and used.The product is control release, and each packet contains eight strands.Upon visual inspection of the returned sample, two needles were observed with a suture piece attached to needle and the end of the suture was observed to be cut by a surgical instrument.In addition, in the same package there were observed, three needle/sutures intact and two needles without suture (one of them with marks due to use).In all the returned needles, the swage and attachment area were noted to be as expected and no defects were detected.Functional test was performed to two used needle/sutures pieces and three strand intact and the pull force results meet the customer requirements.The manufacturing records could not be reviewed as the batch number is unknown.No conclusion could be reached as to what caused the reported.As part of ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Trade name - (b)(6).Active ingredient(s)- triclosan.Dosage form - suture/solid/parenteral.Strength -= 275 g /m.
|